Glutathione can be administered as a shot or a push at the end of IV vitamin therapy
-Safety: Hyaluronic acid based products are considered highly safe
Peptides like sermorelin, ipamorelin, and tesamorelin are gaining traction in fitness and longevity circles for their promise to restore energy, aid weight loss, and build muscle
Reduced-frequency alternatives are practitioner-derived, built on pharmacokinetic reasoning: GHK-Cu has a short circulating half-life, but its tissue remodeling effects are cumulative
We know we should stay away from public water because of toxic components in the water

Key Takeaways Cagrilintide is a long-acting amylin analogue typically dosed at 2.4 mg weekly in clinical trials, working through distinct pathways from GLP-1 receptor agonists Tirzepatide follows a gradual escalation protocol from 2.5 mg to 15 mg weekly as a dual GIP/GLP-1 receptor agonist No approved combination of cagrilintide with tirzepatide currently exists, though the concept represents theoretical triple-pathway metabolic modulation Gastrointestinal side effects require careful monitoring when considering any combination of these peptides due to overlapping mechanisms Clinical evidence for cagrilintide combinations exists primarily with semaglutide, showing 15-17% body weight reductions in phase 3 trials Understanding Cagrilintide: The Amylin Analogue Cagrilintide represents a breakthrough in amylin-based therapeutics, developed by Novo Nordisk as a long-acting analogue of the naturally occurring hormone amylin[1]